Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 1, 2004, Pages 83-89

  Amran, Md Shah ^a   Hashimoto, Keitaro ^a   Homma, Nobuo ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; 2 [4 (2,5 DIFLUOROBENZYLOXY)PHENOXY] 5 ETHOXYANILINE; 2 [4 [(2,5 DIFLUOROPHENYL)METHOXY]PHENYLOXY] 5 ETHOXYANILINE; ACONITINE; CALCIUM ION; NEW DRUG; SODIUM CALCIUM EXCHANGE INHIBITOR; SODIUM ION; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL MODEL; ARTICLE; COMPUTER SIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTROCARDIOGRAM; GUINEA PIG; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; NONHUMAN; PRIORITY JOURNAL; SODIUM CALCIUM EXCHANGE;

EID: 3042688163     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.066951     Document Type: Article

References (37)

1. Adaniya H, Hayami H, Hiraoka M, and Sawanobori T (1994) Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine. J Cardiovasc Pharmacol 24:721-729.
2. Ameri A (1998) The effects of aconitum alkaloids on the central nervous system. Prog Neurobiol 56:211-235.
3. 2+ exchange inhibitor. Cardiovasc Drug Rev 21:255-276.
4. Arita J, Xue XY, Aye NN, Fukuyama K, Wakui Y, Niitsu K, Maruno M, Siying C, and Hashimoto K (1996) Antiarrhythmic effects of an aconitine-like compound, TJN-505, on canine arrhythmia models. Eur J Pharmacol 318:333-340.
5. Aye NN, Komori S, and Hashimoto K (1999) Effects and interaction of cariporide and preconditioning on cardiac arrhythmias and infarction in rat in vivo. Br J Pharmacol 127:1048-1055.
6. Catterall WA (1980) Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes. Annu Rev Pharmacol Toxicol 20:15-43.
7. Catterall WA (1988) Structure and function of voltage-sensitive ion channels. Science (Wash DC) 242:50-61.
8. Catterall WA (2000) From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 26:13-25.
9. Chiang CE and Roden DM (2000) The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 36:1-12.
10. Clancy CE and Rudy Y (1999) Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature (Lond) 400:566-569.
11. Dennis SC, Hearse DJ, and Coltart DJ (1980) Quantitation of ventricular arrhythmias. Eur J Cardiol 12:15-23.
12. Grischenko II, Naumov AP, and Zubov AN (1983) Gating and selectivity of aconitine-modified sodium channels in neuroblastoma cells. Neuroscience 9:549-554.
13. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflueg Arch Eur J Physiol 391:85-100.
14. To) in rat ventricular myocytes. Br J Pharmacol 129:1113-1120.
15. Honerjager P and Meissner A (1983) The positive inotropic effect of aconitine. Naunyn-Schiedeberg's Arch Pharmacol 322:49-58.
16. Isenberg G and Klockner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a "KB medium." Pflueg Arch Eur J Physiol 395:6-18.
17. -. J Biol Chem 274:23094-23102.
18. 2+ exchange in cells expressing NCX1. J Biol Chem 271:22391-22397.
19. 2+ exchange current by KBR in guinea-pig cardiac myocytes. Br J Pharmacol 128:969-974.
20. 2+-overload inhibitor, protects against aconitine induced cardiac arrhythmias in vivo. J Cardiovasc Pharmacol 22:120-125.
21. Luo CH and Rudy Y (1991) A model of the ventricular cardiac action potential. Depolarization, repolarization, and their interaction. Circ Res 68:1501-1526.
22. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298:249-256.
23. 2+ exchange inhibitor, does not suppress ischemia/reperfusion arrhythmias nor digitalis arrhythmias in dogs. Jpn J Pharmacol 90:229-235.
24. Moric E, Herbert E, Trusz-Gluza M, Filipecki A, Mazurek U, and Wilczok T (2003) The implications of genetic mutations in the sodium channel gene (SCN5A). Europace 5:325-334.
25. Nilius B, Boldt W, and Benndorf K (1986) Properties of aconitine-modified sodium channels in single cells of mouse ventricular myocytes. Gen Physiol Biophys 5:473-484.
26. Pfeiffer KP and Kenner T (1983) A statistical approach to the analysis of phenomena of frequency potentiation of isolated myocardial strips. Basic Res Cardiol 78:239-255.
27. 2+ on aconitine-induced arrhythmias. Jpn Heart J 37:709-718.
28. Sawanobori T, Hirano Y, and Hiraoka M (1987) Aconitine-induced delayed after depolarization in frog atrium and guinea-pig papillary muscles in the presence of low concentration of calcium. Jpn J Physiol 37:59-79.
29. Schmidt H and Schmitt O (1974) Effect of aconitine on the sodium permeability of the node of Ranvier. Pflueg Arch Eur J Physiol 349:133-148.
30. 2+ exchange-molecular and pharmacological aspects. Circ Res 88:864-876.
31. Tanaka H, Nishimaru K, Aikawa T, Hirayama W, Tanaka Y, and Shigenobu K (2002) Effect of SEA0400, a novel inhibitor of sodium-calcium exchanger, on myocardial ionic currents. Br J Pharmacol 135:1096-1100.
32. Wallenstein S, Zucker CL, and Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1-9.
33. 2+ exchange inhibitor, KB-R7943 on ouabain-induced arrhythmias in guinea-pigs. Br J Pharmacol 127:1846-1850.
34. 2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119:555-563.
35. Winslow E (1980) Evaluation of antagonism of aconitine-induced dysrhythmias in mice as a method of detecting and assessing antidysrhythmic activity. Br J Pharmacol 71:615-622.
36. Xiao-Li T, Sandro LY, Xiaoping W, Ling W, Mina KC, Patrick JT, David SR, David RVW, Glenn EK, and Qing W (2004) Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo. Cardiovasc Res 61:256-267.
37. Yeih DF, Chiang FT, and Huang SK (2000) Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart 84: E8.